Exos Asset Management’s Repligen RGEN Stock Holding History

Exos Asset Management’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-292	Closed	-$58K	–	655
2021 Q2	$58K	Buy	+292	New	+$56.6K	0.03%	501

Other funds holding RGEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Exos Asset Management's RGEN Position: Q3 2021 in Review

Exos Asset Management sold out of Repligen (RGEN) in Q3 2021, closing a stake of 292 shares — an estimated $58K sold.

Exos Asset Management first reported a position in RGEN in Q2 2021 and held it in 1 quarter. The position peaked at $58K in Q2 2021. 478 funds tracked by Wall St. Rank hold RGEN as of Q3 2021.

Exos Asset Management reported no remaining Repligen position as of Q3 2021 after selling out during the quarter.
Exos Asset Management sold 292 Repligen shares in Q3 2021, an estimated $58K.
Exos Asset Management first reported a position in Repligen in Q2 2021 and held it in 1 quarter.
Exos Asset Management's Repligen position peaked at $58K in Q2 2021.
478 funds tracked by Wall St. Rank held Repligen as of Q3 2021.

Based on Exos Asset Management's 13F filing for Q3 2021, filed 25 Oct 2021.